Article Text
Therapeutics
Randomised controlled trial
In patients with coronary artery disease and heart failure, the addition of coronary-artery bypass grafting to medical therapy has no effect on the overall risk of death from any cause, but assessment of suitability for surgery may predict survival benefit in subgroups
Statistics from Altmetric.com
You do not have access to the full text of this article, the first page of the PDF of this article appears above.
Footnotes
-
Competing interests None.